Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16–26 years in Chongqing, China
Article in Human Vaccines & Immunotherapeutics (December 2023)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Implementing the free HPV vaccination for adolescent girls aged below 14 in Shenzhen, Guangdong Province of China: experience, challenges, and lessons
Article in Infectious Diseases of Poverty (October 2023)
Public health impact of 2-, 4-, and 9-valent HPV vaccination in females on cervical and noncervical diseases in men and women under different coverage scenarios in China: A simulation study
Article in Human Vaccines & Immunotherapeutics (August 2023)